Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Other Operating Expenses of $19.0 million for Q1 2026, up 140.93% on a QoQ basis from $7.9 million in Q4 2016.
Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $19.0 million for Q1 2026.
- Quarterly Other Operating Expenses changed N/A year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (changed N/A YoY) and the FY2016 annual result came in at -$3.8 million, down 19957.5% from the prior year.
- Other Operating Expenses was $19.0 million for Q1 2026 at Arrowhead Pharmaceuticals, up from $7.9 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $19.0 million in Q1 2026 and bottomed at $19.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2016 | 7.89 Mn |
| Sep 30, 2016 | -26.06 Mn |
| Jun 30, 2016 | 7.68 Mn |
| Mar 31, 2016 | 7.47 Mn |
| Dec 31, 2015 | 7.09 Mn |
| Mar 31, 2015 | 45,576.00 |
| Dec 31, 2014 | -26,381.00 |
| Mar 31, 2014 | -5,316.00 |
| Dec 31, 2013 | -53,562.00 |
| Jun 30, 2013 | -39,949.00 |
| Mar 31, 2013 | -54,932.00 |
| Dec 31, 2012 | 18,493.00 |
| Sep 30, 2012 | -169,616.00 |
| Jun 30, 2012 | -876,277.00 |
| Mar 31, 2012 | -33,484.00 |
| Dec 31, 2011 | 2.03 Mn |
| Sep 30, 2011 | 705,244.00 |
| Jun 30, 2011 | 761,382.00 |
| Mar 31, 2011 | 855,506.00 |